Speakers » Harry Meade
TEDxBoston 2012Medicine from Milk Innovation at the intersection of pharmacology and farming where transgenic goats produce vital proteins for drug development
Curator’s Pick: “We have a bioreactor that lives on hay.”
Human proteins are vital ingredients in drug development but the cost to produce them in a factory is exorbitant. Harry Meade found an innovative solution at the intersection of farming and pharmacology where transgenic goats produce proteins in their milk at a fraction of the cost.
Harry Meade, SVP R&D, GTC BiotherapeuticsShow Biography
Harry M. Meade joined GTC Biotherapeutics in 1994, and is a founding member of the company. Dr. Meade directs all transgenic molecular biology research and development efforts conducted within the company, including the evaluation of technologies having potential to increase the efficiencies of transgenic protein expression.
Dr. Meade has over 25 years of research experience, the last ten years’ pertaining to transgenic research and the development of protein expression systems. He has held scientific positions with Genzyme Corporation, Biogen, and Merck. Dr. Meade also is a co-inventor on the first issued patent relating to the production of therapeutic proteins in the milk of animals.
Dr. Meade received his Ph.D. in Biology from the Massachusetts Institute of Technology and completed his post-doctoral studies at Harvard University. He holds Bachelor’s degrees in Chemistry and Electrical Engineering from Union College.Share |